Entradas

Spineart is proud to announce the first surgeries of PERLA® TL, the new Posterior Thoracolumbar Fixation System.

On August 17^th 2020, the first world-wide surgery with the new PERLA® TL Posterior Thoracolumbar Fixation System was successfully performed in the United States by Dr. Vivek Kushwaha from Houston, TX. Shortly after, on September 18^th 2020, the first surgery in Europe was performed by Dr. Strube in Germany.

Dr. Kushwaha commented on the new system that, “The PERLA® TL system is well thought out and intuitive for my staff. With the updated reduction options, dual lead threads and the ability to use a 6.0mm rod, I can efficiently treat a wide range of patients.“

Dr. Strube said “I had a very good feeling with the whole set. Instrumentation worked seamlessly all along the surgery. Screws also felt great with a good grip and a large range of diameters and lengths available.”

PERLA® TL Posterior Thoraco-Lumbar Fixation system combines a compact set of simplified instrumentation with smart instrument design. The system offers a complete range of sterile-packed bar-coded implants, which include pedicle screws with the following innovative features: Friction Tulip Head with Double Rod Diameter Compatibility and a Screw Shaft incorporating a Dual Core Dual Thread design.

Spineart is proud to announce the first surgeries of TRYPTIK®Ti, the new Cervical Cage System.

On August 24^th 2020, the first world-wide surgery with the new TRYPTIK®Ti Cervical Cages was successfully performed in the United States by Dr. Rishi Wadhwa from Shreveport, Louisiana USA. Shortly after, on August 28^th 2020, the first surgery in Europe was performed in Germany.

TRYPTIK®Ti is a cervical cage system utilizing Ti-LIFE Technology, an enhanced manufacturing process of titanium cages based on 3D printing technology, that mimics trabecular bone-like structures.

Spineart is proud to announce the first SCARLET® AL-T ALIF surgeries have been carried out in the UK. The surgeries were successfully completed using our Ti-LIFE Technology cage in the North West and South Wales. Both surgeons are very happy with the clinical outcome and the simplicity of these new instrument sets. We wish the patient’s a speedy recovery.

Spineart is pleased to announce that it has received Investigational Device Exemption (IDE) approval from the FDA to initiate a clinical trial to determine the safety and effectiveness of the BAGUERA® C Cervical Disc Prothesis. The single-level trial will compare the BAGUERA® C Cervical Disc Prothesis to another FDA approved arthroplasty device and will take place in up to 30 centers across the United States.

Jerome Trividic, president of Spineart USA, said, “Thanks to a fruitful collaboration with the FDA, we will be starting patient enrollment in the upcoming months. We are excited to bring BAGUERA® C to the United States, after more than a decade of successful patient outcomes outside the US”.

BAGUERA® C Cervical Disc Prosthesis

The BAGUERA® C Cervical Disc Prosthesis is an MRI compatible disc. The endplates of the BAGUERA® C are anatomically shaped, to accommodate the patient anatomy and to minimize vertebral endplate manipulation. The inner layer of the prosthesis’ endplates are coated with a diamond-like-coating to minimize wear. The load sharing design and the guided mobile nucleus are intended to prevent excessive constraints on the facet joints and adjacent levels.

Spineart USA announces over 1,000 patients treated with SCARLET® AL-T, its ALIF system launched in 2019. The implant was developed using the company’s flagship Ti-LIFE Technology, a titanium bone-like structure that supports bone cell adhesion and allows for bone ingrowth. A number of design features make SCARLET® AL-T unique: the 3D printed cages feature tunnels which prevent screw misalignment, the screws were designed with a triple lead and threaded end-tip, eliminating the need to drill or awl, the screw anti-backout system is both tactile and visual. A line extension with additional lordosis options will be launched later this year, along with the results of an in-vivo animal study, which will be presented at the North American Spine Society annual meeting. SCARLET® AL-T is comprised entirely of sterile packed implants, reducing the risk of contamination or infection.

Spineart is proud to announce the first TEKTONA® Vertebral Fragment Reduction surgery in Colombia. The surgery has been successfully performed by Dr Cesar DIAZ, Neurosurgeon in Hospital San Rafael de Bogota. Dr Diaz is very happy with the clinical outcome and the patient’s fast recovery.